tradingkey.logo
搜索
市场行情
自选
新闻
分析
交易工具
选股器
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
搜索

BioCryst Pharmaceuticals Inc

BCRX
添加自选
8.980USD
-0.260-2.81%
收盘 07-31 16:00（美东）报价延迟15分钟
2.28B总市值
亏损市盈率 TTM

BioCryst Pharmaceuticals Inc

8.980
-0.260-2.81%
概览
财务
分析
公司
财务摘要利润表资产负债表现金流量表

概览

财务

分析

公司

财务摘要利润表资产负债表现金流量表

BCRX 财务数据

通过专为投资者打造的一站式数据看板，全面查看 BioCryst Pharmaceuticals Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

BioCryst Pharmaceuticals Inc财报日历

最新发布
8月 5, 2026
每股收益 / 预测值
--/0.12
营业收入 / 预测值
--/182.51M
查看即将公布的财报 >>
报告期
FY2025 财报
营业收入(YoY)
874.84M
94.10%
每股收益(YoY)
1.26
392.35%
分析师评级
BUY
2026/08/02
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
财务指标
每股收益
-1986446.67%-2.98
1001.90%1.17
190.49%0.06
139.53%0.02
100.09%0.00
57.83%-0.13
64.42%-0.07
84.58%-0.06
39.32%-0.17
19.95%-0.31
---0.19
---0.40
---0.28
---0.38
---0.95
----
----
----
----
----
营业收入
7.48%156.41M
209.09%406.56M
36.14%159.40M
49.41%163.35M
56.89%145.53M
40.83%131.53M
34.98%117.08M
32.54%109.33M
34.87%92.76M
17.42%93.40M
14.39%86.74M
25.88%82.49M
37.77%68.78M
68.68%79.55M
84.97%75.83M
31.17%65.53M
161.94%49.92M
1074.25%47.16M
571.81%40.99M
1640.13%49.96M
净利润
-2255762.50%-721.81M
1017.50%245.84M
191.92%12.90M
140.12%5.08M
100.09%32.00K
56.59%-26.80M
61.18%-14.03M
83.17%-12.67M
33.66%-35.38M
13.71%-61.73M
14.98%-36.15M
-27.98%-75.33M
28.12%-53.33M
-302.39%-71.54M
27.69%-42.52M
-36.25%-58.86M
-15.42%-74.20M
70.61%-17.78M
-27.51%-58.80M
-11.89%-43.20M
利润率
-2098682.40%-461.48%
396.84%60.47%
167.52%8.09%
126.85%3.11%
100.06%0.02%
69.18%-20.37%
71.24%-11.99%
87.31%-11.59%
50.81%-38.14%
26.51%-66.09%
---41.67%
---91.31%
---77.54%
---89.94%
---91.79%
----
----
----
----
----
毛利率
-0.31%96.56%
2.43%97.66%
1.42%98.63%
-0.13%98.29%
-1.66%96.86%
-2.96%95.34%
-1.47%97.24%
-0.44%98.41%
-0.14%98.50%
1.43%98.25%
--98.69%
--98.85%
--98.64%
--96.86%
--97.86%
----
----
----
----
----
资产负债率
6.33%181.72%
-46.33%91.11%
-10.92%151.05%
-10.33%159.68%
-5.16%170.91%
4.57%169.76%
6.43%169.57%
15.17%178.07%
22.99%180.21%
21.77%162.35%
--159.33%
--154.62%
--146.53%
--133.32%
--127.76%
----
----
----
----
----
利润表
营业收入
7.48%156.41M
209.09%406.56M
36.14%159.40M
49.41%163.35M
56.89%145.53M
40.83%131.53M
34.98%117.08M
32.54%109.33M
34.87%92.76M
17.42%93.40M
14.39%86.74M
25.88%82.49M
37.77%68.78M
68.68%79.55M
84.97%75.83M
31.17%65.53M
161.94%49.92M
1074.25%47.16M
571.81%40.99M
1640.13%49.96M
营业利润
-118.08%-3.84M
5876.06%260.38M
284.70%29.59M
239.98%29.79M
246.51%21.23M
89.44%-4.51M
164.52%7.69M
142.32%8.76M
49.01%-14.49M
7.86%-42.67M
31.67%-11.92M
40.37%-20.70M
43.12%-28.41M
11.24%-46.31M
60.87%-17.45M
-17.38%-34.72M
2.76%-49.96M
0.44%-52.18M
-4.01%-44.58M
23.18%-29.58M
净利润
-2255762.50%-721.81M
1017.50%245.84M
191.92%12.90M
140.12%5.08M
100.09%32.00K
56.59%-26.80M
61.18%-14.03M
83.17%-12.67M
33.66%-35.38M
13.71%-61.73M
14.98%-36.15M
-27.98%-75.33M
28.12%-53.33M
-302.39%-71.54M
27.69%-42.52M
-36.25%-58.86M
-15.42%-74.20M
70.61%-17.78M
-27.51%-58.80M
-11.89%-43.20M
资产负债表
流动资产
-8.87%373.63M
-4.18%404.35M
-16.73%355.68M
9.63%398.46M
-8.30%409.98M
-14.92%421.97M
-14.99%427.13M
-28.88%363.46M
-8.92%447.10M
-3.98%495.97M
-1.28%502.47M
3.27%511.06M
-4.07%490.88M
-8.77%516.50M
101.39%509.00M
86.17%494.85M
86.91%511.71M
74.84%566.14M
55.60%252.74M
30.40%265.80M
流动负债总额
39.71%195.39M
22.25%196.07M
23.88%190.24M
37.26%177.16M
16.62%139.85M
6.93%160.38M
69.20%153.57M
38.04%129.06M
40.82%119.92M
42.15%149.99M
11.18%90.76M
-1.98%93.50M
5.11%85.16M
1.73%105.51M
-38.90%81.64M
-17.48%95.39M
-19.94%81.02M
-1.83%103.72M
19.53%133.61M
12.62%115.60M
总资产
-3.12%465.05M
4.84%514.16M
-9.13%446.42M
-3.22%457.19M
2.60%480.05M
-5.13%490.42M
-6.06%491.25M
-10.84%472.42M
-8.21%467.89M
-6.01%516.96M
-6.39%522.92M
3.79%529.88M
-3.41%509.74M
-6.49%550.00M
110.19%558.59M
84.12%510.54M
85.54%527.72M
75.72%588.15M
50.81%265.76M
29.15%277.28M
总负债
9.33%1.02B
-34.46%633.31M
-13.08%834.31M
-7.30%878.78M
-1.28%931.97M
-0.63%966.35M
2.77%959.82M
3.20%948.02M
12.65%944.06M
15.14%972.49M
16.56%933.91M
26.92%918.60M
21.11%838.02M
21.50%844.60M
94.10%801.25M
88.80%723.77M
92.51%691.93M
96.38%695.14M
189.51%412.81M
177.40%383.36M
总权益
-22.55%-553.84M
74.96%-119.15M
17.22%-387.89M
11.36%-421.59M
5.09%-451.93M
-4.48%-475.93M
-14.01%-468.56M
-22.35%-475.61M
-45.05%-476.17M
-54.63%-455.53M
-69.37%-410.99M
-82.30%-388.71M
-99.91%-328.29M
-175.36%-294.60M
-65.02%-242.66M
-101.02%-213.23M
-118.99%-164.22M
-455.43%-106.99M
-537.15%-147.04M
-238.65%-106.08M
现金流量表
经营净额
-124.56%-61.79M
5700.61%291.96M
404.84%41.62M
3119.15%41.30M
48.74%-27.52M
41.55%-5.21M
141.44%8.24M
92.73%-1.37M
-12.99%-53.68M
62.61%-8.92M
38.67%-19.90M
32.22%-18.81M
38.93%-47.51M
26.53%-23.85M
-39.39%-32.44M
-9.23%-27.76M
-27.52%-77.80M
23.68%-32.46M
39.16%-23.28M
18.14%-25.41M
投资净额
-1091.50%-268.65M
-569.11%-83.49M
59.88%13.57M
1289.34%29.13M
-5.78%27.09M
162.50%17.80M
-63.28%8.49M
87.13%-2.45M
126.85%28.76M
-136.87%-28.47M
133.24%23.12M
80.46%-19.04M
-178.41%-107.11M
794.38%77.22M
-997.68%-69.54M
-2263.37%-97.44M
-362.20%-38.47M
-151.93%-11.12M
122.74%7.75M
191.32%4.50M
融资净额
77887.15%412.55M
-5320.54%-217.96M
-4716.48%-58.81M
-3648.02%-73.69M
150.48%529.00K
-26.73%-4.02M
4.00%1.27M
-106.70%-1.97M
-120.64%-1.05M
-175.57%-3.17M
-98.40%1.23M
19870.07%29.36M
-30.98%5.08M
-98.79%4.20M
1498.09%76.33M
-96.79%147.00K
153.66%7.36M
76.57%347.42M
203.06%4.78M
-95.77%4.57M

常见问题

BioCryst Pharmaceuticals Inc的总收入是多少？

根据BioCryst Pharmaceuticals Inc的FY2025财报，总收入达到了874.84M（同比变化450.71M）。

BioCryst Pharmaceuticals Inc的流动资产是多少？

根据BioCryst Pharmaceuticals Inc的FY2025财报，流动资产为404.35M（同比变化-4.18）。

BioCryst Pharmaceuticals Inc的总资产是多少？

根据BioCryst Pharmaceuticals Inc的FY2025财报，BioCryst Pharmaceuticals Inc的总资产为514.16M（同比变化4.84）。

BioCryst Pharmaceuticals Inc的总负债是多少？

根据BioCryst Pharmaceuticals Inc的FY2025财报，BioCryst Pharmaceuticals Inc的总负债为633.31M（同比变化-34.46）。

BioCryst Pharmaceuticals Inc的总权益是多少？

根据BioCryst Pharmaceuticals Inc的FY2025财报，BioCryst Pharmaceuticals Inc的总权益为-119.15M（同比变化74.96）。

BioCryst Pharmaceuticals Inc的净营业收入是多少？

根据BioCryst Pharmaceuticals Inc的FY2025财报，BioCryst Pharmaceuticals Inc的净营业收入为340.99M（同比变化13508.93）。

BioCryst Pharmaceuticals Inc的净投资是多少？

根据BioCryst Pharmaceuticals Inc的FY2025财报，BioCryst Pharmaceuticals Inc的净投资为-13.69M（同比变化-126.04）。

BioCryst Pharmaceuticals Inc的净融资是多少？

根据BioCryst Pharmaceuticals Inc的FY2025财报，BioCryst Pharmaceuticals Inc的净融资为-349.93M（同比变化-5974.14）。

BioCryst Pharmaceuticals Inc的每股收益（EPS）是多少？

根据BioCryst Pharmaceuticals Inc的FY2025财报，每股收益（EPS）为1.26（同比变化392.35）。

BioCryst Pharmaceuticals Inc的净利润是多少？

根据BioCryst Pharmaceuticals Inc的FY2025财报，净利润为263.86M（同比变化396.87）。

BioCryst Pharmaceuticals Inc的净利润率是多少？

根据BioCryst Pharmaceuticals Inc的FY2025财报，净利润率为30.16（同比变化252.95）。

BioCryst Pharmaceuticals Inc的毛利率是多少？

根据BioCryst Pharmaceuticals Inc的FY2025财报，毛利率为97.82（同比变化0.61）。

BioCryst Pharmaceuticals Inc的债务与资产比率是多少？

根据BioCryst Pharmaceuticals Inc的FY2025财报，债务与资产比率为91.11（同比变化-46.33）。

BioCryst Pharmaceuticals Inc的资产回报率（ROA）是多少？

根据BioCryst Pharmaceuticals Inc的FY2025财报，资产回报率（ROA）为52.53（同比变化397.70）。

BioCryst Pharmaceuticals Inc的营业利润是多少？

根据BioCryst Pharmaceuticals Inc的FY2025财报，营业利润为340.99M（同比变化13508.93）。
tradingkey.logo
风险提示：我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐，且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险，包括可能损失投资的本金，且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告，并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有
一般使用条款
隐私政策
Cookie政策